Clinical Trials

779 enrolled 9 charts

Breast Neoplasms, Neoplasm Metastasis

NCT03822468 2025-10-16

AMALEE

376 enrolled 17 charts

Breast Neoplasms

NCT03778931 2025-09-15

EMERALD

478 enrolled 16 charts 1 FDA

Breast Neoplasms

NCT05549505 2025-08-29

A Trial Using ARV-471 or Anastrozole in Post-Menopausal Women With Breast Cancer Prior to Surgery

152 enrolled 16 charts

Breast Neoplasms

NCT03909152 2025-07-28

A Study of Onapristone ER Alone Or In Combination With Anastrozole in Gynecologic Cancers That Respond to Progesterone

34 enrolled 9 charts

Gynecologic

Granulosa Cell Ovarian Cancer

NCT03099174 2025-06-24

This Study in Patients With Different Types of Cancer (Solid Tumours) Aims to Find a Safe Dose of Xentuzumab in Combination With Abemaciclib With or Without Hormonal Therapies. The Study Also Tests How Effective These Medicines Are in Patients With Lung and Breast Cancer

Phase 1 Completed

133 enrolled 26 charts

Breast Neoplasms, Neoplasms

NCT00253422 2025-06-04

SoFEA

698 enrolled 19 charts

Breast Neoplasms

NCT02040857 2025-04-29

Palbociclib in Combination With Adjuvant Endocrine Therapy for Hormone Receptor Positive, HER2 Negative Invasive Breast Cancer

162 enrolled 12 charts

Breast Neoplasms

NCT03219476 2025-04-29

Neoadjuvant Endocrine Therapy in Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2 (HER2)-Negative Node-Negative Breast Cancer

37 enrolled 10 charts

Breast Neoplasms

NCT00265759 2025-04-23

Exemestane, Letrozole, or Anastrozole in Treating Postmenopausal Women Who Are Undergoing Surgery for Stage II or Stage III Breast Cancer

622 enrolled 18 charts

Breast Neoplasms

NCT03691493 2025-02-17

ASPIRE

36 enrolled 17 charts

Breast Neoplasms

NCT04294225 2025-01-28

Anastrozole and Letrozole After Surgery for the Treatment of Stage I-III Breast Cancer

161 enrolled 12 charts

Breast Neoplasms

NCT01216176 2025-01-08

A Pharmacokinetic and Randomized Trial of Neoadjuvant Treatment With Anastrozole Plus AZD0530 in Postmenopausal Patients With Hormone Receptor Positive Breast Cancer

Phase 1/2 Completed

71 enrolled 15 charts

Breast Neoplasms

NCT03839823 2024-10-09

RIGHT Choice

222 enrolled 17 charts

Breast Neoplasms

NCT02648477 2024-03-19

Pembrolizumab and Doxorubicin Hydrochloride or Anti-Estrogen Therapy in Treating Patients With Triple-Negative or Hormone Receptor-Positive Metastatic Breast Cancer

30 enrolled 11 charts

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT00295646 2024-03-15

Tamoxifen Versus Anastrozole, Alone or in Combination With Zoledronic Acid

1,803 enrolled 20 charts

Breast Neoplasms

NCT02278120 2024-03-12

MONALEESA-7

672 enrolled 16 charts 1 FDA

Advanced Metastatic Breast Cancer

NCT03321981 2024-03-07

MCLA-128 With Trastuzumab/Chemotherapy in HER2+ and With Endocrine Therapy in ER+ and Low HER2 Breast Cancer.

105 enrolled 23 charts

Lethal Congenital Contracture Syndrome 2

NCT01814397 2024-02-07

Pilot Study to Evaluate the Effect of Aromatase Inhibitor Therapy on Pain Threshold in Breast Cancer Patients

50 enrolled 15 charts

Breast Neoplasms, Pain, Arthralgia

NCT00066573 2023-08-25

Exemestane or Anastrozole in Treating Postmenopausal Women Who Have Undergone Surgery for Primary Breast Cancer

7,576 enrolled 10 charts

Breast Neoplasms

NCT00921115 2023-05-19

Anti-Hormone Therapy (With Anastrazole and Fulvestrant) Before Surgery to Treat Postmenopausal Women With Breast Cancer.

42 enrolled 5 charts

Breast Neoplasms

NCT04436744 2023-02-02

A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Giredestrant Plus Palbociclib Compared With Anastrozole Plus Palbociclib for Postmenopausal Women With Estrogen Receptor-Positive and HER2-Negative Untreated Early Breast Cancer (coopERA Breast Cancer)

221 enrolled 21 charts

Breast Neoplasms

NCT01791985 2022-08-22

RADICAL

Phase 1/2 Completed

52 enrolled 17 charts

Breast Neoplasms

NCT00405938 2021-11-18

Bevacizumab Given With Either Anastrozole or Fulvestrant With Trastuzumab for Postmenopausal Metastatic Breast Cancer

79 enrolled 7 charts

Breast Neoplasms

NCT00256217 2021-05-11

Chemoprevention Trial - Anastrozole in Ductal Carcinoma In Situ (DCIS) in Postmenopausal Women

42 enrolled 10 charts

Carcinoma, Intraductal, Noninfiltrating

NCT00871858 2021-02-24

HORGEN

120 enrolled 11 charts

Breast Neoplasms

NCT01004744 2021-01-11

Pre-Surgical Intervention for Targeted Therapies for Breast Cancer

10 enrolled 4 charts

Invasive Breast Cancer

NCT00570323 2020-07-28

PACT001

72 enrolled 8 charts

Breast Neoplasms

NCT02441946 2020-06-17

neoMONARCH

224 enrolled 20 charts

Breast Neoplasms

NCT02291913 2020-02-17

Everolimus Combined With Anti-estrogen Therapy in Hormone-Receptor-Positive HER-2 Negative Advanced Breast Cancer

48 enrolled 13 charts

Breast Neoplasms

NCT01720602 2020-01-07

Vorinostat in Treating Patients With Stage IV Breast Cancer Receiving Hormone Therapy

15 enrolled 10 charts

Breast Neoplasms, Breast Neoplasms, Male

NCT00186121 2019-10-07

Estradiol Suppression for the Treatment of Metastatic Breast Cancer in Premenopausal Women

35 enrolled 11 charts

Breast Neoplasms

NCT00295620 2019-10-02

SALSA

3,484 enrolled 18 charts

Breast Neoplasms

NCT02093351 2019-10-02

To Assess Safety and Effect of Olaparib on the Pharmacokinetics of Anastrozole, Letrozole & Tamoxifen, and Their Effect on Olaparib, in Patients With Advanced Solid Cancer

Phase 1 Completed

79 enrolled 35 charts

Tumor-Agnostic

Neoplasms

NCT01153672 2019-09-06

Vorinostat in Treating Patients With Stage IV Breast Cancer Receiving Aromatase Inhibitor Therapy

8 enrolled 10 charts

Breast Neoplasms, Breast Neoplasms, Male

NCT00179517 2019-07-17

Treatment of Sexual Dysfunction in Hypogonadal Men With Epilepsy With Testosterone and Either Anastrozole or Placebo

40 enrolled 13 charts

EndocrineOther

Epilepsy, Hypogonadism, Erectile Dysfunction, Seizures, Sexual Dysfunction, Physiological, Multiple Endocrine Neoplasia Type 1

NCT01597193 2019-05-08

Safety Study of Enzalutamide (MDV3100) in Patients With Incurable Breast Cancer

Phase 1 Completed

101 enrolled 33 charts

Breast Neoplasms

NCT00111241 2018-12-14

Changes in Knee Articular Cartilage Volume in Women on Aromatase Inhibitors

115 enrolled 6 charts

Breast Neoplasms, Osteoporosis, Arthralgia, Fractures, Bone

NCT00728949 2018-06-06

A Study for Safety and Effectiveness of IMC-A12 by Itself or Combined With Antiestrogens to Treat Breast Cancer

93 enrolled 14 charts

Breast Neoplasms

NCT00612560 2017-10-12

FABrC

28 enrolled 14 charts

Breast Neoplasms

NCT01896050 2016-06-28

LOGRIBMET

115 enrolled 14 charts

BreastOther

Breast Neoplasms, Obesity, Arthralgia

NCT00248170 2016-04-19

FACE

4,172 enrolled 7 charts

Breast Neoplasms

NCT00217399 2014-05-28

Sorafenib and Anastrozole in Treating Postmenopausal Women With Metastatic Breast Cancer

Phase 1/2 Completed

35 enrolled 9 charts

Breast Neoplasms

NCT00057941 2014-05-12

Anastrozole and ZD1839 Compared With Fulvestrant and ZD1839 in Postmenopausal Women w/ Metastatic Breast Cancer

148 enrolled 7 charts

Breast Neoplasms

NCT00354640 2013-06-24

Simvastatin and Anastrozole in Treating Postmenopausal Women With Ductal Carcinoma In Situ or Invasive Breast Cancer

11 enrolled 5 charts

Breast Carcinoma In Situ, Breast Neoplasms, Carcinoma, Intraductal, Noninfiltrating

NCT00022672 2013-06-13

A Study to Evaluate the Efficacy and Safety of Herceptin® (Trastuzumab) in Combination With Arimidex® (Anastrozole) an Aromatase Inhibitor Compared to Arimidex® Alone in Patients With Metastatic Breast Cancer

208 enrolled 20 charts

Breast Neoplasms

NCT00005908 2013-03-19

Primary Chemotherapy With Docetaxel-Capecitabine and Doxorubicin-Cyclophosphamide in Breast Cancer

30 enrolled 12 charts

Breast Neoplasms

NCT00537771 2013-01-25

HEART

Phase 4 Completed

384 enrolled 9 charts

Breast Neoplasms

NCT00605267 2012-09-06

Arimidex/Tamoxifen Neo Adjuvant Study in Premenopausal Patients With Breast Cancer Under Anti Hormonal Treatment

197 enrolled 23 charts